Literature DB >> 9863543

Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury.

G E Hill1, J A Miller, B T Baxter, L W Klassen, M J Duryee, D J Tuma, G M Thiele.   

Abstract

Atherosclerosis is a vascular injury characterized by elevated tissue levels of tumor necrosis factor-alpha (TNF-alpha), increased expression of endothelial cell adhesion molecules, and vascular wall inflammatory cell infiltration. Foam cells are associated with atherosclerotic plaque material, and low density lipoprotein (LDL) is a lipid component of foam cells. Malondialdehyde (MDA) is an oxidative product of unsaturated fatty acids and is also present in atherosclerotic lesions. MDA-modified (adducted) proteins, including MDA-modified LDL, are present in atherosclerotic human vascular tissue. Acetaldehyde (AA) is the major metabolic product of ethanol oxidation. Both MDA and AA are highly reactive aldehydes and will combine with proteins to produce an antigenically distinct protein adduct, termed the MAA adduct. This study demonstrates that proteins modified in the presence of high concentrations of MDA can produce MAA-modified proteins in vitro. In addition, MAA adducted proteins are capable of inducing rat heart endothelial cell cultures (rHEC) to produce and release TNF-alpha, and cause rHEC upregulation of endothelial adhesion molecule expression, including ICAM-1. These adhesion molecules are required for circulating inflammatory cells to adhere to endothelium which allows inflammatory cell tissue infiltration. Additionally, MAA modified proteins were defected in human atherosclerotic aortic vascular tissue but not in normal aortic tissue. Since atherosclerosis is associated with an inflammatory vascular injury characterized by elevated tissue TNF-alpha concentrations and inflammatory cell infiltration, these data suggest that MAA-adducted proteins may be formed in atherosclerotic plaque material and may be involved in the inflammatory reaction that occurs in atherosclerosis. These data further suggest that previous studies demonstrating MDA modified protein in atherosclerotic plaque may in fact have MAA modified proteins associated with them.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9863543     DOI: 10.1016/s0021-9150(98)00153-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  26 in total

Review 1.  Immunological response in alcoholic liver disease.

Authors:  Michael J Duryee; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

2.  Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis joint.

Authors:  Ted R Mikuls; Michael J Duryee; Rafid Rahman; Daniel R Anderson; Harlan R Sayles; Andrew Hollins; Kaleb Michaud; Frederick Wolfe; Geoffrey E Thiele; Jeremy Sokolove; William H Robinson; Nithya Lingampalli; Anthony P Nicholas; Geoffrey A Talmon; Kaihong Su; Matthew C Zimmerman; Lynell W Klassen; Geoffrey M Thiele
Journal:  Rheumatology (Oxford)       Date:  2017-10-01       Impact factor: 7.580

3.  Aldehydes potentiate alpha(2)(I) collagen gene activity by JNK in hepatic stellate cells.

Authors:  F A Anania; L Womack; M Jiang; N K Saxena
Journal:  Free Radic Biol Med       Date:  2001-04-15       Impact factor: 7.376

4.  Identification of novel bioactive aldehyde-modified phosphatidylethanolamines formed by lipid peroxidation.

Authors:  Lilu Guo; Zhongyi Chen; Venkataraman Amarnath; Sean S Davies
Journal:  Free Radic Biol Med       Date:  2012-08-04       Impact factor: 7.376

5.  Phosphatidylethanolamines modified by γ-ketoaldehyde (γKA) induce endoplasmic reticulum stress and endothelial activation.

Authors:  Lilu Guo; Zhongyi Chen; Brian E Cox; Venkataraman Amarnath; Raquel F Epand; Richard M Epand; Sean S Davies
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

6.  Malondialdehyde-Acetaldehyde-Adducted Surfactant Protein Alters Macrophage Functions Through Scavenger Receptor A.

Authors:  Muna Sapkota; Kusum K Kharbanda; Todd A Wyatt
Journal:  Alcohol Clin Exp Res       Date:  2016-10-26       Impact factor: 3.455

7.  Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.

Authors:  Geoffrey M Thiele; Michael J Duryee; Daniel R Anderson; Lynell W Klassen; Stephen M Mohring; Kathleen A Young; Dathe Benissan-Messan; Harlan Sayles; Anand Dusad; Carlos D Hunter; Jeremy Sokolove; William H Robinson; James R O'Dell; Anthony P Nicholas; Dean J Tuma; Ted R Mikuls
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

8.  Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis.

Authors:  Michael J Duryee; Lynell W Klassen; Courtney S Schaffert; Dean J Tuma; Carlos D Hunter; Robert P Garvin; Daniel R Anderson; Geoffrey M Thiele
Journal:  Free Radic Biol Med       Date:  2010-08-06       Impact factor: 7.376

9.  Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts.

Authors:  Geoffrey M Thiele; Michael J Duryee; Carlos D Hunter; Bryant R England; Benjamin S Fletcher; Eric C Daubach; Taylor P Pospisil; Lynell W Klassen; Ted R Mikuls
Journal:  Int Immunopharmacol       Date:  2020-03-27       Impact factor: 4.932

10.  Malondialdehyde-acetaldehyde (MAA) adducted proteins bind to scavenger receptor A in airway epithelial cells.

Authors:  John P Berger; Samantha M Simet; Jane M DeVasure; Jessica A Boten; Jenea M Sweeter; Kusum K Kharbanda; Joseph H Sisson; Todd A Wyatt
Journal:  Alcohol       Date:  2014-05-11       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.